gms | German Medical Science

31. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

21.11. - 22.11.2024, Bonn

Abstracts

Meeting Abstract (24gaa01)

Efficacy and adverse drug reactions of antidepressants from the perspective of laypersons

Apel K, Scheel-Barteit J, Kühlein T, Sebastiao M
[Full Text]
Meeting Abstract (24gaa02)

Metamizole utilisation at a German neonatal intensive care unit between 2013 and 2022

Bachmat I, Haering-Zahn J, Neubert A, Eberl S
[Full Text]
Meeting Abstract (24gaa03)

Outpatient urinary tract infections in Germany – a cross-sectional study on practices of susceptibility testing in medical laboratories

Bender H, Jobski K, Schmiemann G, Hamprecht A, Hoffmann F
[Full Text]
Meeting Abstract (24gaa04)

Development of a standardized questionnaire for patient-reported outcomes of adverse drug reactions

Berres J, Fölsch H, Neiß J, Krzoska D, Just KS, Stingl JC
[Full Text]
Meeting Abstract (24gaa05)

Incorrect route of drug administration: analysis of spontaneous medication error reports in children and adolescents

Domgörgen S, Dubrall D, Kayser C, Toni I, Ströbel A, Neubert A, Sachs B
[Full Text]
Meeting Abstract (24gaa06)

Women’s Preferences for the Use of Herbal Medicinal Products for Gynecological Ailments: Analysis from the PhytoVIS Database

Drebka A, Scholl AJ, Ochs T, Mösges R, Bachmeier BE
[Full Text]
Meeting Abstract (24gaa07)

Variables associated with the completeness of information provided in spontaneous adverse drug reaction reports of physicians, pharmacists and consumers

Dubrall D, Christ P, Domgörgen S, Schmid M, Sachs B
[Full Text]
Meeting Abstract (24gaa08)

Trends in Use of Antipsychotics in Germany 2014–2023: A Nationwide Population-based Study

Espinosa Daudí A, Kieble M, Schulz M
[Full Text]
Meeting Abstract (24gaa09)

MAMA: Microbiome changes due to antibiotic prophylaxis in mothers at birth – a pioneering clinical study

Feles E, Mattner F, Neidhöfer C, Sieber M, Leuko S, Moeller R
[Full Text]
Meeting Abstract (24gaa10)

Young, well-educated people and their self-medication products – information behavior, appropriate situations and fears

Gebert I, Hundertmark S, Bertsche T
[Full Text]
Meeting Abstract (24gaa11)

CoVacU18-Study: Long-Term Safety of mRNA-based COVID-19 vaccine BNT162b2 in Children under 18 Years in Germany

Grieshaber V, Strumann C, Holzwarth S, Toepfner N, von Meissner WCG, Konstantopoulos N, von Poblotzki M, Hensel KO, Moor MB, Chao CM
[Full Text]
Meeting Abstract (24gaa12)

The assessment guide “Drug therapy: Notes on off-label use”: an update by the Medizinischen Dienst (Medical Service)

Grimmsmann T
[Full Text]
Meeting Abstract (24gaa13)

Sex-specific changes in diagnostic categories and psychotropic drug prescriptions to 12- to 17-year-olds with AOK insurance before and after the COVID-19 pandemic

Hach I, Langner I, Selke G, Hansel M, Eichler U
[Full Text]
Meeting Abstract (24gaa14)

TI-compliant role-based messaging to support intersectoral communication between nursing homes, general practitioner offices and pharmacies

Jungesblut M, Shimada D, Altrichter D, Kurtz P, Eigendorf J, Leitsmann M, Szecsenyi J
[Full Text]
Meeting Abstract (24gaa15)

Introduction of a unit dose supply in the context of closed-loop medication management at a clinic of the University Hospital Jena (UKJ) – acceptance and feasibility from the ward staff point of view – first results

Keßler C, Kwetkat A, Meissner F, Krusche I, Seeling A, Bleidorn J, Hartmann M, Katrin F
[Full Text]
Meeting Abstract (24gaa16)

Methotrexate related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance

Khoroshun K, Bantel C, Hoffmann F, Jobski K
[Full Text]
Meeting Abstract (24gaa17)

Interprofessional education for training the recognition of adverse drug reactions – perspectives from psychology students

Krüger T, Radermacher JC, Sarömba J, Neiß J, Krzoska D, Just K
[Full Text]
Meeting Abstract (24gaa18)

Development of the HPV vaccination rate and the incidence of cervical cancer – a study with SHI routine data

Lappe V, Schubert I, Grandt D
[Full Text]
Meeting Abstract (24gaa19)

ABLYMED – ability to self-administer medication in non-demented in-hospital patients

Lügering A, Langner R, Wilm S, Doeppner TR, Hermann DM, Frohnhofen H, Gronewold J
[Full Text]
Meeting Abstract (24gaa20)

Research project VAC-MAC – VACcination of Multiple sclerosis/Arthritis/Colitis patients – comparison of vaccination-related adverse events between MAC patients

Meiszl K, Denz R, Tokic MC, Basten J, Hellwig K, Grüter T, Oganowski T, Stock S, Simic D, Shukri A, Kiltz U, Zacharopoulou M, Vollmar H, Otte I, Lauer R, Suslow A, Stallmach A, Franz A, Marschall U, Saam J, Schumacher C, van de Sand H, Meyer I, Timmesfeld N
[Full Text]
Meeting Abstract (24gaa21)

Information-seeking behavior of pregnant women in Germany regarding pharmacotherapy use: insecurities, attitude and support through health care professionals. A study protocol

Melcher N
[Full Text]
Meeting Abstract (24gaa22)

Developing a procedure for criteria-based quality assessment of educational material

Picker E, Rediker G, Wurmbach V, Seidling H
[Full Text]
Meeting Abstract (24gaa23)

Patient-Reported Outcomes of Antidepressant Drug Therapy: A Comparative Analysis between Acute Psychiatric, Outpatient Psychiatric and Geriatric Patients

Radermacher J, Wozniak J, Just K, Berres J, Stingl J
[Full Text]
Meeting Abstract (24gaa24)

Potentially inappropriate medication use based on PRISCUS 2.0: prevalence and association with the occurrence of falls – results from the POLAR_MI project

Redeker L, Mussawy B, Härterich S, Kesselmeier M, Rottenkolber M, Schmidt F, Thürmann P, Schmiedl S
[Full Text]
Meeting Abstract (24gaa25)

Drug shortages: reasons, extent and implications

Rose O, Hoti K, Isufi B, Pachmayr J, Hartl A, Giesen H, Clemens S
[Full Text]
Meeting Abstract (24gaa26)

Single-Arm Trials Supplemented With External Control Arms – First Investigation on Breast Cancer and Amyotrophic Lateral Sclerosis Trials in German Real-World Data Sources

Russek M, Peltner J, Becker C, Pfeifer K, Roethlein C, Haenisch B
[Full Text]
Meeting Abstract (24gaa27)

Adverse drug event-related hospital admissions: Population-based cohort study in two Scottish health boards

Schechner M, Weglage C, Rottenkolber M, Dreischulte T
[Full Text]
Meeting Abstract (24gaa28)

Real-World Data from the Database PhytoVIS on Herbal Medicinal Products for Mental Health Issues: An Analysis of Treatment Habits among Users

Scholl AJ, Drebka A, Ochs T, Mösges R, Frenzel SB, Raskopf E, Shah-Hosseini K, Bachmeier BE
[Full Text]
Meeting Abstract (24gaa29)

Growing regional differences by urbanity and socioeconomic deprivation in the prescription prevalence of opioid analgesics for non-cancer pain: results based on German claims data from 2004 to 2020

Scholle O, Jobski K, Viebrock J, Haug U
[Full Text]
Meeting Abstract (24gaa30)

Pseudo-worsening of kidney function due to inhibition of renal creatinine secretion: Overview of perpetrating drugs and analysis of German and US Summaries of Product Characteristics (SmPCs)

Sponfeldner M, Andrikyan W, Maas R, Fromm M
[Full Text]
Meeting Abstract (24gaa31)

Off-label prescribing in paediatric general and specialised outpatient clinics – is there a difference?

Toni I, Hupfer J, Eberl S, Neubert A
[Full Text]